<?xml version="1.0" encoding="UTF-8"?>
<abstract id="Abs3" abstract-type="KeyPoints">
 <title>Key points</title>
 <p id="Par3">
  <list list-type="bullet">
   <list-item>
    <p id="Par4">Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), shares many biological features with SARS-CoV, the virus that causes severe acute respiratory syndrome, owing to 80% genomic sequence identity.</p>
   </list-item>
   <list-item>
    <p id="Par5">The interaction between the viral spike (S) protein and angiotensin-converting enzyme 2, which triggers entry of the virus into host cells, is likely to be involved in the cardiovascular manifestations of COVID-19.</p>
   </list-item>
   <list-item>
    <p id="Par6">The presence of underlying cardiovascular comorbidities in patients with COVID-19 is associated with high mortality.</p>
   </list-item>
   <list-item>
    <p id="Par7">COVID-19 can cause cardiovascular disorders, including myocardial injury, arrhythmias, acute coronary syndrome and venous thromboembolism.</p>
   </list-item>
   <list-item>
    <p id="Par8">Several medications used for the treatment of COVID-19 have uncertain safety and efficacy profiles.</p>
   </list-item>
  </list>
 </p>
</abstract>
